vs

Side-by-side financial comparison of Citius Pharmaceuticals, Inc. (CTXR) and High Roller Technologies, Inc. (ROLR). Click either name above to swap in a different company.

High Roller Technologies, Inc. is the larger business by last-quarter revenue ($6.3M vs $3.9M, roughly 1.6× Citius Pharmaceuticals, Inc.). High Roller Technologies, Inc. runs the higher net margin — 58.4% vs -238.2%, a 296.6% gap on every dollar of revenue.

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies addressing unmet medical needs across critical care, oncology, anti-infective treatment, and supportive care segments, primarily serving the U.S. healthcare market.

S&S – Sansei Technologies is an American company known for its pneumatically powered amusement rides and roller coaster designing.

CTXR vs ROLR — Head-to-Head

Bigger by revenue
ROLR
ROLR
1.6× larger
ROLR
$6.3M
$3.9M
CTXR
Higher net margin
ROLR
ROLR
296.6% more per $
ROLR
58.4%
-238.2%
CTXR

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CTXR
CTXR
ROLR
ROLR
Revenue
$3.9M
$6.3M
Net Profit
$-9.4M
$3.7M
Gross Margin
80.0%
Operating Margin
-228.7%
1.3%
Net Margin
-238.2%
58.4%
Revenue YoY
-16.4%
Net Profit YoY
8.6%
831.9%
EPS (diluted)
$-0.38
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTXR
CTXR
ROLR
ROLR
Q4 25
$3.9M
Q3 25
$6.3M
Q2 25
$6.9M
Q1 25
$6.8M
Q3 24
$7.5M
Net Profit
CTXR
CTXR
ROLR
ROLR
Q4 25
$-9.4M
Q3 25
$3.7M
Q2 25
$-592.0K
Q1 25
$-3.3M
Q3 24
$-501.0K
Gross Margin
CTXR
CTXR
ROLR
ROLR
Q4 25
80.0%
Q3 25
Q2 25
Q1 25
Q3 24
Operating Margin
CTXR
CTXR
ROLR
ROLR
Q4 25
-228.7%
Q3 25
1.3%
Q2 25
-7.2%
Q1 25
-47.4%
Q3 24
-6.3%
Net Margin
CTXR
CTXR
ROLR
ROLR
Q4 25
-238.2%
Q3 25
58.4%
Q2 25
-8.5%
Q1 25
-48.4%
Q3 24
-6.7%
EPS (diluted)
CTXR
CTXR
ROLR
ROLR
Q4 25
$-0.38
Q3 25
$0.39
Q2 25
$-0.07
Q1 25
$-0.39
Q3 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTXR
CTXR
ROLR
ROLR
Cash + ST InvestmentsLiquidity on hand
$7.7M
$2.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$80.0M
$6.6M
Total Assets
$140.4M
$16.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTXR
CTXR
ROLR
ROLR
Q4 25
$7.7M
Q3 25
$2.7M
Q2 25
$2.7M
Q1 25
$3.5M
Q3 24
$1.3M
Stockholders' Equity
CTXR
CTXR
ROLR
ROLR
Q4 25
$80.0M
Q3 25
$6.6M
Q2 25
$2.6M
Q1 25
$2.8M
Q3 24
$-779.0K
Total Assets
CTXR
CTXR
ROLR
ROLR
Q4 25
$140.4M
Q3 25
$16.0M
Q2 25
$12.3M
Q1 25
$12.8M
Q3 24
$12.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTXR
CTXR
ROLR
ROLR
Operating Cash FlowLast quarter
$-13.0M
$-78.0K
Free Cash FlowOCF − Capex
$-90.0K
FCF MarginFCF / Revenue
-1.4%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTXR
CTXR
ROLR
ROLR
Q4 25
$-13.0M
Q3 25
$-78.0K
Q2 25
$-840.0K
Q1 25
$-3.6M
Q3 24
Free Cash Flow
CTXR
CTXR
ROLR
ROLR
Q4 25
Q3 25
$-90.0K
Q2 25
$-845.0K
Q1 25
$-3.6M
Q3 24
FCF Margin
CTXR
CTXR
ROLR
ROLR
Q4 25
Q3 25
-1.4%
Q2 25
-12.2%
Q1 25
-53.5%
Q3 24
Capex Intensity
CTXR
CTXR
ROLR
ROLR
Q4 25
Q3 25
0.2%
Q2 25
0.1%
Q1 25
0.2%
Q3 24
Cash Conversion
CTXR
CTXR
ROLR
ROLR
Q4 25
Q3 25
-0.02×
Q2 25
Q1 25
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTXR
CTXR

Segment breakdown not available.

ROLR
ROLR

Net Gaming Revenue$4.9M77%
Net Revenue Noncore Services$1.4M23%

Related Comparisons